Vivos Therapeutics, Inc. (VVOS) — Gross Profit
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $10.54M | +16.9% |
| 2024 | $9.02M | +9.0% |
| 2023 | $8.27M | -17.4% |
| 2022 | $10.02M | -20.5% |
| 2021 | $12.60M | +21.0% |
| 2020 | $10.41M | +20.3% |
| 2019 | $8.66M | — |
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $10.54M | +16.9% |
| 2024 | $9.02M | +9.0% |
| 2023 | $8.27M | -17.4% |
| 2022 | $10.02M | -20.5% |
| 2021 | $12.60M | +21.0% |
| 2020 | $10.41M | +20.3% |
| 2019 | $8.66M | — |